Afifi A., Zellweger H., McCormick WF: Congenital muscular dystrophy: Light and electron microscopic observations . J Neurol Neurosurg Psychiatry1969;32:273-280.
2.
Donner M., Rapola J., Somer H.: Congenital muscular dystrophy: A clinico-pathological and follow-up study of 15 patients. Neuropadiatrie1975;6:239-258.
3.
Pearson CM, Fowler WG Jr: Hereditary non-progressive muscular dystrophy inducing arthrogryposis syndrome . Brain1963;86:75-88.
Fukuyama Y., Kawazura M., Haruna H.: A peculiar form of congenital progressive muscular dystrophy. Report of 15 cases. Paediatria Universitatis ( Tokyo) 1960;4:5-8.
6.
Nonaka I., Chou SM: Congenital muscular dystrophy, in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology, vol 41. New York, Elsevier/ North Holland, Inc, 1980, pp 27-50.
7.
Tome FM, Evangelista T., Leclerc A., et al: Congenital muscular dystrophy with merosin deficiency. Comp Rend Acad Sci Ser III Sci Vie1974;317:351-357.
8.
Hillaire D., Leclerc A., Faure S., et al: Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Molec Genet1994;3:1657-1661.
9.
Matsumura K. , Campbell KP: Dystrophin-glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve1994;17:2-15.
10.
Philpot J., Sewry C., Pennock J., Dubowitz V.: Clinical phenotype in congenital muscular dystrophy: Correlation with expression of merosin in skeletal muscle. Neuromusc Dis1995 ;5:301-305.
11.
Pegoraro E. , Mancias P., Swerdlow SH, et al: Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy . Ann Neurol1996;40:782-791.
12.
Munsat TL, Piper D., Cancilla P., Mednick J.: Inflammatory myopathy with facioscapulohumeral distribution. Neurology1972;22:335-347.